493 related articles for article (PubMed ID: 22681436)
1. Current regulatory approaches of bioequivalence testing.
Karalis V; Macheras P
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
[TBL] [Abstract][Full Text] [Related]
2. Variability and impact on design of bioequivalence studies.
Van Peer A
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
[TBL] [Abstract][Full Text] [Related]
3. Critical considerations into the new EMA guideline on bioequivalence.
Marzo A; Fontana E
Arzneimittelforschung; 2011; 61(4):207-20. PubMed ID: 21650079
[TBL] [Abstract][Full Text] [Related]
4. Some thoughts on drug interchangeability.
Chow SC; Song F; Chen M
J Biopharm Stat; 2016; 26(1):178-86. PubMed ID: 26366703
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence and other unresolved issues in generic drug substitution.
Meredith P
Clin Ther; 2003 Nov; 25(11):2875-90. PubMed ID: 14693311
[TBL] [Abstract][Full Text] [Related]
6. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence studies for levothyroxine.
Bolton S
AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the bioavailability and bioequivalence of generic medications.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):13-6. PubMed ID: 20102127
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic equivalence of complex drugs.
Schellekens H; Klinger E; Mühlebach S; Brin JF; Storm G; Crommelin DJ
Regul Toxicol Pharmacol; 2011 Feb; 59(1):176-83. PubMed ID: 20951177
[TBL] [Abstract][Full Text] [Related]
10. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
[TBL] [Abstract][Full Text] [Related]
11. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
Bialer M; Midha KK
Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products.
Adiguzel C; Jeske WP; Hoppensteadt D; Walenga JM; Bansal V; Fareed J
Clin Appl Thromb Hemost; 2009; 15(2):137-44. PubMed ID: 19357102
[TBL] [Abstract][Full Text] [Related]
13. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
14. Clinical Endpoint Bioequivalence Studies Are Needed: A Perspective From Brand Drugs.
Krishna R; Kesisoglou F
Clin Pharmacol Ther; 2019 Feb; 105(2):298-300. PubMed ID: 30456848
[No Abstract] [Full Text] [Related]
15. Regulatory Considerations of Bioequivalence Studies for Oral Solid Dosage Forms in Japan.
Kuribayashi R; Takishita T; Mikami K
J Pharm Sci; 2016 Aug; 105(8):2270-7. PubMed ID: 27372551
[TBL] [Abstract][Full Text] [Related]
16. Is Bioequivalence a Sufficient Measure of Equivalence?
Holman A
J Leg Med; 2019; 39(3):247-261. PubMed ID: 31626574
[TBL] [Abstract][Full Text] [Related]
17. On safety margin for drug interchangeability.
Zheng J; Chow SC; Song F
J Biopharm Stat; 2017; 27(2):293-307. PubMed ID: 27911675
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence testing of immunosuppressants: concepts and misconceptions.
Christians U; Klawitter J; Clavijo CF
Kidney Int Suppl; 2010 Mar; (115):S1-7. PubMed ID: 20150904
[TBL] [Abstract][Full Text] [Related]
19. Generic drugs in dermatology: part II.
Payette M; Grant-Kels JM
J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
[TBL] [Abstract][Full Text] [Related]
20. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
Meredith PA
Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]